TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

You Are Here: Home  »  Research  »  Parkinson's Disease Research Web  »  Udall Centers  »  Annual Meetings  »  14th Annual Udall Center Directors' Meeting  » 

Skip secondary menu

2012 NINDS Udall Centers Meeting Agenda

14th Annual Udall Center Directors' Meeting
October 1-3, 2012
Washington Plaza Hot
Washington, DC

Summary  Participant List  Executive Summary



Monday October 1, 2012. Udall Center Clinical Cores Meeting

11:00 a.m.
NINDS Data Management Resource (DMR) for Parkinson’s Disease Research. Margaret L. Sutherland, Ph.D./ NINDS, NIH
11:20 a.m.
11:20 a.m
Overview of Udall Center Clinical Cores
11:30 a.m.
Robert E. Burke, M.D./Columbia University
11:50 a.m.
Andrew Feigin, M.D./Feinstein Institute for Medical Research
12:10 p.m.
Susan S. Bassett, Ph.D./Johns Hopkins University School of Medicine
12:30 p.m.
William K. Scott, M.D./University of Miami
12:50 p.m.
Working Lunch
1:20 p.m.
Zbigniew K. Wszolek, M.D./The Mayo Clinic Jacksonville
1:40 p.m.
Rachel Gross, M.D./University of Pennsylvania
2:00 p.m.
James Leverenz, M.D./University of Washington
2:20 p.m.
Focused Discussion: Collaborative Opportunities
2:45 p.m.
Genetics studies in Udall Center cohorts. Moderator: Jeffery M. Vance, M.D., Ph.D./Director, University of Miami Udall Center
3:30 p.m.
Cognitive decline and Parkinson’s disease with dementia (PDD): studies in Udall Center cohorts. Moderator: John Q. Trojanowski, M.D., Ph.D./Director, University of Pennsylvania Udall Center
4:15 p.m.
Harmonization of clinical measures and standardization of data collection across Udall Center cohorts. Moderator: Thomas J. Montine, M.D., Ph.D., Director, Pacific Northwest Udall Center
5:00 p.m.
Discussion: Identification of next steps
5:30 p.m.


Tuesday October 2, 2012. Udall Center Directors' Meeting

8:00 a.m.
8:30 a.m.
Opening Remarks/NINDS Update. Story C. Landis, Ph.D./ Director, NINDS, NIH
9:00 a.m.
Robert E. Burke, M.D., 2012 Chair, Udall Center Coordinating Committee (UC3), Director, Columbia University Udall Center
Beth‐Anne Sieber, Ph.D., Program Director, NINDS, NIH
Cross-cutting Discussion Topics
9:30 a.m.
The PINK1‐Parkin Connection
Introduction. Robert E. Burke, M.D./Director, Columbia University Udall Center
Do PINK1 and Parkin promote mitochondrial turnover in neurons?. Leo J. Pallanck, Ph.D./University of Washington
Therapeutic strategies to mitigate mitochondrial dysfunction in Parkinson’s disease and beyond. Richard Youle, Ph.D./NINDS, NIH
The regulation of mitochondrial movement in neurons. Thomas L Schwarz, Ph.D./Harvard Medical School
11:30 a.m.
Lunch Presentation
Biomedical research: a congressional update. Amy Comstock Rick, Esq./Chief Executive Officer, Parkinson’s Action Network
11:30 a.m.
Udall Center Administrators’ Lunch Meeting. Janice Savage, M.S./Columbia University
12:30 p.m.
Beyond the basal ganglia: the role of thalamus, cerebellum, and cortex in the pathophysiology of Parkinson’s disease
Introduction. Thomas Wichmann, M.D., Ph.D./Director, Emory University Udall Center
The thalamus in Parkinson’s disease. Yoland Smith, Ph.D./Emory University
Thalamocortical dysfunction in Parkinson’s disease. Robert S. Turner, Ph.D./University of Pittsburgh
Basal ganglia loops with the cerebral cortex and cerebellum. Peter L. Strick, Ph.D./University of Pittsburgh
2:30 p.m.
3:00 p.m.
New insights on the genetics of Parkinson’s disease
Introduction. Dennis W. Dickson, M.D., Ph.D./Director, Mayo Clinic Jacksonville Udall Center
Next generation methods to discover new PD genes. Andrew Singleton, Ph.D./National Institute on Aging, NIH
Mega meta analyses of clinical PD GWAS and the NeuroChip Initiative. Tatiana Foroud, Ph.D./Indiana University
Autopsy‐verified PD GWAS: emerging results. Jeffery M. Vance, M.D., Ph.D./Director, University of Miami Udall Center
5:00 p.m.
Poster Session and Judging
6:30 p.m.
NINDS–NGOs Meeting


Wednesday October 3, 2012. Udall Center Updates: Significant Advances

8:30 a.m.
A new model of Parkinson’s disease based on transmission of pathological alpha‐synuclein. Virginia M.‐Y. Lee, Ph.D., M.B.A./University of Pennsylvania Udall Center
9:00 a.m.
Toward understanding PD pathogenesis and how to stop progression. D. James Surmeier, Ph.D./Director, Northwestern University Udall Center
9:30 a.m.
Mitochondrial biogenesis: The rest of the story. Ted M. Dawson, M.D., Ph.D./Director, Johns Hopkins University Udall Center
10:00 a.m.
Axon regeneration by mTor signaling: neurorestoration for Parkinson’s disease. Robert E. Burke, M.D./Director, Columbia University Udall Center
10:30 a.m.
11:00 a.m.
Synaptic remodeling in the parkinsonian striatum: impact of age and levodopa. Timothy Collier, Ph.D./Director, Michigan State University Udall Center
11:30 a.m.
Abnormal network activity in prodromal Parkinson’s disease. David Eidelberg, M.D./Director, Feinstein Institute for Medical Research Udall Center
12:00 p.m.
Pacific Northwest Udall Center: Updates on cognitive impairment in PD. Thomas J. Montine, M.D., Ph.D./Director, Pacific Northwest Udall Center (PANUC) at the University of Washington
12:30 p.m.
Rare variants in Parkinson’s disease. Jeffery M. Vance, M.D., Ph.D./Director, University of Miami Udall Center
1:00 p.m.
Closing Remarks
Story Landis, Ph.D./Director, NINDS, NIH
Thomas J. Montine, M.D., Ph.D./2013 Chair, Udall Center Coordinating Committee (UC3), Director, Pacific Northwest Udall Center (PANUC)
1:15 p.m.
Adjournment (Udall investigators and guests)
1:15 p.m.
Udall Center Coordinating Committee (UC3) Meeting
2:00 p.m.
NINDS Udall Center Directors' Meeting Adjournment

Last Modified October 18, 2015